Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01EX Other antiglaucoma preparations
S01EX05 Netarsudil
D11031 Netarsudil mesylate (USAN) <US>
USP drug classification [BR:br08302]
Ophthalmic Agents
Intraocular Pressure Lowering Agents
Prostaglandin and Prostamide Analogs, Ophthalmic
Netarsudil
D11031 Netarsudil mesylate (USAN)
Drug groups [BR:br08330]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG02692 Netarsudil
D11031 Netarsudil mesylate
Drug classes [BR:br08332]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
D11031 Netarsudil mesylate
Target-based classification of drugs [BR:br08310]
Protein kinases
Serine/threonine kinases
AGC group
ROCK
D11031 Netarsudil mesylate (USAN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11031
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11031
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11031
Drug groups [BR:br08330]
Ophthalmic agent
DG03201 Intraocular pressure lowering agent
DG02692 Netarsudil